JJ Erasmus, HP McAdams, SE Rossi… - American Journal of …, 2000 - Am Roentgen Ray Soc
OBJECTIVE. We determined the ability of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) to differentiate benign and malignant pleural effusions in patients with …
KB Sriram, V Relan, BE Clarke, EE Duhig… - Future …, 2011 - Taylor & Francis
Malignant pleural effusions (MPEs) are a common and important cause of cancer-related mortality and morbidity. Prompt diagnosis using minimally invasive tests is important …
Introduction The purpose of this study was to investigate the potential value of certain biomarkers in predicting the presence of malignant pleural mesothelioma (MPM) in …
JS Toaff, U Metser, M Gottfried, O Gur… - Investigative …, 2005 - journals.lww.com
Objectives: We sought to define an accurate diagnostic approach for differentiating benign from malignant pleural effusion on positron emission tomography–computed tomography …
SA Sahn - Pleural disease, 2009 - taylorfrancis.com
I. Introduction Malignant pleural effusions, a common consequence of malignancy, cause substantial morbidity for those inflicted. With the virtual epidemic of lung cancer and breast …
Y Aydin, A Turkyilmaz, YS Intepe… - The Eurasian journal of …, 2009 - ncbi.nlm.nih.gov
Malignant pleural effusion (MPE) is a common and important clinical condition. A complication in many types of tumors, its presence indicates the onset of the terminal stages …
Over the last 20 yr, the introduction of immunocytochemistry as a diagnostic tool has dramatically revolutionized diagnostic pathology. With the introduction of molecular methods …
R Loddenkemper - Pneumologie, 2005 - thieme-connect.com
Maligne Pleuraergüsse mit ihrem Hauptsymptom Atemnot sind ein häufiges Problem bei Patienten mit bösartigen Tumorerkrankungen. Verantwortlich führend ist der Lungenkrebs …